Effectiveness of Maternal Respiratory Syncytial Virus Vaccination in Conferring Infant Immunity: Review and Future

Masatoki Kaneko1,2, Junsuke Muraoka1

  • 1Department of Obstetrics and Gynecology, Faculty of Medicine, University of Miyazaki, Miyazaki 889-1692, Japan.

Vaccines
|March 27, 2026
PubMed

Insights

Respiratory syncytial virus (RSV) causes severe infant infections. Antibody-based strategies, including vaccines and maternal immunization, are crucial for preventing RSV, with the F glycoprotein as a key target.

Area of Science:

  • Virology
  • Immunology
  • Vaccinology

Background:

  • Respiratory syncytial virus (RSV) is a major cause of infant respiratory illness globally.
  • Natural immunity to RSV is not durable, leading to reinfections and severe early-life disease.
  • Current preventive strategies face challenges in providing long-term protection.

Purpose of the Study:

  • To review antibody-mediated prevention of RSV infection.
  • To evaluate vaccine development and maternal immunization strategies for RSV.
  • To analyze RSV pathogenesis, immune evasion, and antigenic characteristics for vaccine design.

Main Methods:

  • Review of current evidence on RSV pathogenesis and immune evasion.
  • Focus on viral surface glycoproteins, particularly the F protein, as targets.
  • Evaluation of licensed vaccines, monoclonal antibodies, and maternal immunization data.

Main Results:

  • The RSV fusion (F) glycoprotein is the primary target for neutralizing antibodies and current interventions.
  • The F protein shows constrained evolution, maintaining intervention effectiveness despite antigenic drift in other proteins.
  • Waning antibody titers necessitate ongoing passive immunization strategies for infants.

Conclusions:

  • Maternal vaccination and long-acting monoclonal antibodies are significant advances in infant RSV protection.
  • Equitable global access to these interventions remains a challenge.
  • Continued monitoring of viral evolution and antibody durability is essential for optimizing immunization strategies.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.1K
Vaccinations01:51

Vaccinations

Overview
53.7K
Active versus Passive Immunity01:31

Active versus Passive Immunity

Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
12.0K
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
24
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.6K
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
41